TY - JOUR
T1 - A novel diagnostic algorithm for heparin-induced thrombocytopenia
AU - Zheng, G.
AU - Streiff, M. B.
AU - Allison, D.
AU - Takemoto, C. M.
AU - Salimian, K.
AU - Morris, P.
AU - Jani, J.
AU - McCord, R.
AU - Kickler, T. S.
N1 - Publisher Copyright:
© 2018 John Wiley & Sons Ltd
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/10
Y1 - 2018/10
N2 - Introduction: While diagnostic algorithm using PF4-heparin enzyme-linked immunosorbent assay (ELISA) optical density (OD), and heparin neutralization assay (HNA), or 4T score have been proposed to replace serotonin-release assay (SRA) for heparin-induced thrombocytopenia (HIT), their performance against SRA is unclear. In this study, we proposed and validated the performance of a new algorithm combining PF4-heparin ELISA optical density (OD), HNA and 4T score against SRA for HIT diagnosis. Methods: Heparin neutralization assays were performed on specimens submitted for HIT testing with positive PF4-heparin ELISA from December 2015 to September 2017, which were separated into a “training” and a “validation” data set. 4T scores were calculated for ELISA positive cases. Results: A total of 123 consecutive unique patient samples had positive PF4-heparin ELISA with also HNA data, SRA data, and 4T scores available. Compared to SRA, a “laboratory criteria” (ELISA OD ≥ 1.4 and HNA ≥ 70%) had a sensitivity of 88% (14/16) and specificity of 91% (42/46), and a “combined criteria” (4T score = 8, or 4T score = 6 or 7 and ELISA OD ≥ 1.0, or 4T score = 4 or 5 and ELISA OD ≥ 2.0) had a sensitivity of 75% (12/16) and specificity of 98% (45/46) in the training data set. Laboratory and combined criteria had 90% (56/62) concordance rate. Importantly, for these concordant cases, the diagnostic specificity is 100% (46/46). Based on the data, a novel diagnostic algorithm combining these 2 criteria was proposed and validated prospectively. Conclusion: A novel algorithm has high diagnostic accuracy and potentially could eliminate the need for SRA testing in at least 90% patients with suspected HIT.
AB - Introduction: While diagnostic algorithm using PF4-heparin enzyme-linked immunosorbent assay (ELISA) optical density (OD), and heparin neutralization assay (HNA), or 4T score have been proposed to replace serotonin-release assay (SRA) for heparin-induced thrombocytopenia (HIT), their performance against SRA is unclear. In this study, we proposed and validated the performance of a new algorithm combining PF4-heparin ELISA optical density (OD), HNA and 4T score against SRA for HIT diagnosis. Methods: Heparin neutralization assays were performed on specimens submitted for HIT testing with positive PF4-heparin ELISA from December 2015 to September 2017, which were separated into a “training” and a “validation” data set. 4T scores were calculated for ELISA positive cases. Results: A total of 123 consecutive unique patient samples had positive PF4-heparin ELISA with also HNA data, SRA data, and 4T scores available. Compared to SRA, a “laboratory criteria” (ELISA OD ≥ 1.4 and HNA ≥ 70%) had a sensitivity of 88% (14/16) and specificity of 91% (42/46), and a “combined criteria” (4T score = 8, or 4T score = 6 or 7 and ELISA OD ≥ 1.0, or 4T score = 4 or 5 and ELISA OD ≥ 2.0) had a sensitivity of 75% (12/16) and specificity of 98% (45/46) in the training data set. Laboratory and combined criteria had 90% (56/62) concordance rate. Importantly, for these concordant cases, the diagnostic specificity is 100% (46/46). Based on the data, a novel diagnostic algorithm combining these 2 criteria was proposed and validated prospectively. Conclusion: A novel algorithm has high diagnostic accuracy and potentially could eliminate the need for SRA testing in at least 90% patients with suspected HIT.
KW - 4T score
KW - PF4-heparin ELISA
KW - heparin neutralization assay
KW - heparin-induced thrombocytopenia
KW - serotonin-release assay
UR - http://www.scopus.com/inward/record.url?scp=85053256362&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053256362&partnerID=8YFLogxK
U2 - 10.1111/ijlh.12853
DO - 10.1111/ijlh.12853
M3 - Article
C2 - 29756276
AN - SCOPUS:85053256362
SN - 1751-5521
VL - 40
SP - 527
EP - 532
JO - International Journal of Laboratory Hematology
JF - International Journal of Laboratory Hematology
IS - 5
ER -